Global Health & Biotech Archives | Page 66 of 292 | Be Korea-savvy

Archive by category Global Health & Biotech

KFSH&RC Achieves Remarkable 98% Survival Rate in 400 Robotic Cardiac Surgeries

KFSH&RC Achieves Remarkable 98% Survival Rate in 400 Robotic Cardiac Surgeries

RIYADH, Saudi Arabia, Jul. 4 (Korea Bizwire) — King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of today, 400 robotic cardiac surgeries have been performed with a [...]

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (Korea Bizwire) – Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. [...]

IVI RMA Global and Lavima Fertility Join Forces in Research in Fertility Treatments

IVI RMA Global and Lavima Fertility Join Forces in Research in Fertility Treatments

VALENCIA, Spain and BRUSSELS, July 03, 2024 (Korea Bizwire) – Seeking alternatives to obtain oocytes without ovarian stimulation is a pioneering line of research in reproductive medicine. The inconveniences that the process of ovarian stimulation can generate are a current barrier for some women and couples who are considering starting a reproductive treatment. In fact, [...]

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea [...]

Olon Group Announces the Acquisition of GTP Bioways Group

Olon Group Announces the Acquisition of GTP Bioways Group

MILAN, July 03, 2024 (Korea Bizwire) – GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufacturing Organisation), specialising in R&D Services, process development and production of mAbs, enzymes, proteins, nanodrugs, ADCs and F&F. GTP Bioways Group, with multiple locations across France, specializes in delivering comprehensive services to biopharmaceutical companies. From [...]

Philips Appoints Ling Liu as Chief Region Leader of Philips Greater China

Philips Appoints Ling Liu as Chief Region Leader of Philips Greater China

July 3, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips’ Executive Committee, reporting to Philips CEO Roy Jakobs. She succeeds Andy [...]

Ascom and Almaviva Sign a Strategic Collaboration Agreement for the Digitalization of Care Delivery in Italy with Digistat

Ascom and Almaviva Sign a Strategic Collaboration Agreement for the Digitalization of Care Delivery in Italy with Digistat

Baar, Switzerland, 2 July 2024 Ascom and Almaviva, an Italian leading information and communication technology company, have entered a strategic partnership to drive the digital transformation of the Italian healthcare sector. As part of this partnership, Ascom has been commissioned with significant Digistat projects for patient data management, including professional services and software. Further projects are [...]

Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

Mr. Oliveira is an accomplished biopharmaceutical industry executive with nearly 25 years of commercial experience, building high-performing teams, and launching multiple successful pharmaceutical products WALTHAM, Mass., July 01, 2024 (Korea Bizwire) – Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based therapies, today announced the appointment [...]

KFSHRC Performs Over 5,000 Successful Kidney Transplants

KFSHRC Performs Over 5,000 Successful Kidney Transplants

RIYADH, Saudi Arabia, July 01, 2024 (Korea Bizwire) – King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of its Transplant Program in 1981, placing it among a select group of leading global health centres that have achieved this milestone. Last year alone, KFSHRC has performed 80 [...]

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company submitted the fourth and final module [...]